Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Look for Shares of Veracyte Inc to Potentially Rebound after Yesterday's 1.92% Sell Off

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $24.48 to a high of $25.69. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $24.59...

VCYT : 24.18 (-4.50%)
Shares of Pfenex Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (PFNX, VCYT , KPTI , GBT , REGN )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

KPTI : 10.59 (-2.49%)
VCYT : 24.18 (-4.50%)
PFNX : 9.18 (+3.15%)
Veracyte Inc Rises 4.08% on Heavy Volume: Watch For Potential Pullback

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $23.30 to a high of $24.30. Yesterday, the shares gained 4.1%, which took the trading range above the 3-day high of $23.89...

VCYT : 24.18 (-4.50%)
Veracyte to Release Third Quarter 2019 Financial Results and Business Progress on October 22, 2019

Veracyte, Inc. (Nasdaq: VCYT) today announced that it will release its financial results for the third quarter 2019 and business progress after the close of market on Tuesday, October 22, 2019. Company...

VCYT : 24.18 (-4.50%)
Veracyte to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST Annual Meeting 2019

Veracyte, Inc. (Nasdaq: VCYT) today announced that preliminary clinical data for the company's noninvasive nasal swab test - the first of its kind - for early detection of lung cancer will be presented...

VCYT : 24.18 (-4.50%)
After Yesterday's Decline of 1.02%, Veracyte Inc Offers Investors Better Value

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $23.68 to a high of $24.56. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $24.43...

VCYT : 24.18 (-4.50%)
Personalis Appoints Karin Eastham to Its Board of Directors

Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, today announced that it has appointed Karin Eastham as an independent director to its Board of Directors. Ms. Eastham brings more...

ILMN : 307.77 (-0.90%)
MOR : 27.65 (+0.33%)
VCYT : 24.18 (-4.50%)
PSNL : 11.60 (-5.15%)
Veracyte Announces Publication of Clinical and Analytical Validation Data for Afirma Xpression Atlas

Veracyte, Inc. (Nasdaq: VCYT) today announced the publication of new data demonstrating the clinical and analytical validity of its Afirma(R) Xpression Atlas (XA) genomic test, which is used to help guide...

VCYT : 24.18 (-4.50%)
Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer

Veracyte, Inc. (Nasdaq: VCYT) today announced the publication of new data that further define the genomic landscape around thyroid cancer. The study findings help characterize the role of specific gene...

VCYT : 24.18 (-4.50%)
Veracyte to Present at Upcoming Investor Conferences

Veracyte, Inc. (Nasdaq: VCYT) today announced that Bonnie H. Anderson, chairman and chief executive officer, will present at the following upcoming investor conferences:

MS : 43.35 (-0.21%)
WFC : 50.03 (+0.85%)
VCYT : 24.18 (-4.50%)
Relatively Good Performance Detected in Shares of Epizyme Inc in the Biotechnology Industry (EPZM , AIMT , VCYT , NVTA , FLXN )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

AIMT : 25.00 (-1.15%)
EPZM : 10.39 (-0.76%)
VCYT : 24.18 (-4.50%)
Veracyte (VCYT) Reports Q2 Loss, Tops Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of 44.44% and 3.20%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

VCYT : 24.18 (-4.50%)
Veracyte: 2Q Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) _ Veracyte Inc. (VCYT) on Tuesday reported a loss of $2.5 million in its second quarter.

VCYT : 24.18 (-4.50%)
Will Veracyte (VCYT) Report Negative Earnings Next Week? What You Should Know

Veracyte (VCYT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

VCYT : 24.18 (-4.50%)
Look for Shares of Veracyte Inc to Potentially Rebound after Yesterday's 3.15% Sell Off

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $28.26 to a high of $29.08. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $28.65...

VCYT : 24.18 (-4.50%)
Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019

Veracyte, Inc. (Nasdaq: VCYT) today announced that it will release its financial results for the second quarter 2019 after the close of market on Tuesday, July 30, 2019. Company management will host a...

VCYT : 24.18 (-4.50%)
Veracyte Announces Next-Generation Percepta Genomic Sequencing Classifier Now Available to Physicians for Improved Lung Cancer Diagnosis

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, today announced that it has begun making its next-generation Percepta(R) Genomic Sequencing Classifier (GSC) available to physicians,...

VCYT : 24.18 (-4.50%)
Veracyte Named a San Francisco Bay Area "Top Workplace" For Sixth Consecutive Year

Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced today that the company has been awarded a Top Workplaces 2019 honor by the Bay Area News Group for the sixth consecutive...

VCYT : 24.18 (-4.50%)
Veracyte (VCYT) Hits Fresh High: Is There Still Room to Run?

Veracyte (VCYT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

VCYT : 24.18 (-4.50%)
TCMD : 47.57 (-2.18%)
HOLX : 49.74 (+0.79%)
IART : 62.57 (+0.98%)
Look for Shares of Veracyte Inc to Potentially Pullback after Yesterday's 1.26% Rise

Veracyte Inc (NASDAQ:VCYT) traded in a range yesterday that spanned from a low of $24.67 to a high of $24.96. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $24.53...

VCYT : 24.18 (-4.50%)

Van Meerten Stock Picks

The 5 Best Large Caps
I wanted to find which Large Caps had the best momentum so I used Barchart to sort the S&P 500 Large Cap Index first by the highest technical buy signals, then by the most frequent number of new highs in the last month.
CCI +4.49 , AIZ -0.03 , SBAC +2.20 , SO -0.18 , WELL +0.75
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

InsideFutures Commentary

InsideFutures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar